| Literature DB >> 33799911 |
Rajbardhan Mishra1, Lenka Rajsiglová1,2, Pavol Lukáč1,2, Paolo Tenti1,2, Peter Šima1, Fabián Čaja1,2, Luca Vannucci1.
Abstract
Cancer, bacteria, and immunity relationships are much-debated topics in the last decade. Microbiome's importance for metabolic and immunologic modulation of the organism adaptation and responses has become progressively evident, and models to study these relationships, especially about carcinogenesis, have acquired primary importance. The availability of germ-free (GF) animals, i.e., animals born and maintained under completely sterile conditions avoiding the microbiome development offers a unique tool to investigate the role that bacteria can have in carcinogenesis and tumor development. The comparison between GF animals with the conventional (CV) counterpart with microbiome can help to evidence conditions and mechanisms directly involving bacterial activities in the modulation of carcinogenesis processes. Here, we review the literature about spontaneous cancer and cancer modeling in GF animals since the early studies, trying to offer a practical overview on the argument.Entities:
Keywords: colorectal cancer; germ-free animals; induced tumors; microbiome; spontaneous tumors
Year: 2021 PMID: 33799911 PMCID: PMC8002107 DOI: 10.3390/medicina57030260
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Spontaneous tumors in conventional experimental rats and mice.
| CV Spontaneous | Incidence % | Main Types of Tumors | Strain | Gender | n. of Animals | Time of Observation | Year | Citation |
|---|---|---|---|---|---|---|---|---|
| Rats | 45% | endocrine | Sprague-Dawley | ♂ | 179 | up to 18 months | 1973 | [ |
| mammary gland endocrine | ♀ | 181 | ||||||
| Mice | 26% | lung | Swiss | ♂ | 101 | up to 18 months | 1973 | [ |
| lung | ♀ | 153 | ||||||
| 36% | mammary gland | C3Hf/Pi | ♀ | 392 | up to 24 months | 1967 | [ | |
| 37% | small bowel—polyposis | BALB/c | ♀ | 41 | 12 months | 1984 | [ | |
| 51% | ♂ | 51 | ||||||
| 82% | liver | C3H/He | ♂ | 17 | 11 months (48 weeks) | 1979 | [ |
Abbreviations—CV: conventional; Balb: Bagg albino mouse strain; C3H: mouse strain and its variants; F344: Fisher 344 rat strain.
Spontaneous tumors in germ-free (GF) experimental rats and mice.
| GF Spontaneous | Incidence % | Main Types of Tumors | Strain | Gender | n. of Animals | Time of Observation | Year | Citation |
|---|---|---|---|---|---|---|---|---|
| Rats | 25/? * | mamary gland, thymus | wistar | ♀, ♂ | 359 | up to 38 months | 1963 | [ |
| 0 ** | - | fisher | ||||||
| 0 ** | - | sprague-dawley | ||||||
| 0% | - | wistar | ♀, ♂ | 33 | older than 24 months | 1970 | [ | |
| 13% | prostate | wistar | ♂ | 31 | 20–40 months | 1973 | 30 | |
| 19.6% ♀ | mamary gland | F344 | ♀ | 78♂ | from 7 months to >3 years | 1976 | [ | |
| 11.5% ♂ | ♂ | |||||||
| 36% ♀ | leukaemia | ♀ | 102♀ | |||||
| 25.6% ♂ | ♂ | |||||||
| Mice | 30% | mamary gland | C3H/Pi | ♀ | 66 | up to 24 months | 1967 | [ |
| 21% | lung | BALB/cPi | ♀, ♂ | 67 (15♂, 52♀) | median age 21 months | 1971 | [ | |
| 3% | mamary gland | |||||||
| 4.5% | lympho-sarcoma | |||||||
| 3% | reticulum cell sarcoma | |||||||
| 3% | skin carcinoma | |||||||
| 3% | adrenal cortical carcinoma | |||||||
| 1.5% | ovaries | ♀ | ||||||
| 14/? * | leukaemia | AK | ns | ns | mean age 8,7 months | 1965 | [ | |
| 68% | small bowell—polyposis | BALB/c | ♀ | 40 | 12 months | 1984 | [ | |
| 89% | ♂ | 36 | ||||||
| 39% | liver | C3H/He | ♂ | 49 | 11 months (48 weeks) | 1979 | [ |
(*) unknown number of total Wistar rats, here only the absolute number of tumor bearing animals; (**) all animals negative for tumor in the observed strain.
Tumor occurrence in GF rats and mice induced with chemical carcinogens.
| Induced Tumors | Chemical | Method of Administation | Incidence GF % | Incidence CV % | Main Types of Tumors | Strain | Gender | n. of Animals | Age of Animals at the Start of Experiment | Year | Citation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rats | DMBA + 15% fat emulsion | intra peritoneal | 56% | 67% | mammary gland, leukaemia | Sprague-Dawley | ♂ | 18 GF (−2†) | 1 month | 1967 | [ |
| 11 (−5†) CV | |||||||||||
| 100% | myeloid leukaemia | Fisher | 18 GF (−16†) | ||||||||
| DMBA in sesame oil | stomach tube | 100% | 89% | breast | Sprague-Dawley | ♀ | 11 (−2†) GF | 2 months | 1963 | [ | |
| 29 (−11†)CV | |||||||||||
| 20% | 0% | Fisher | ♀ | 8 GF | |||||||
| 12 CV | |||||||||||
| all died because of cytotoxicity | 0% | Wistar | ♀ | 15 (−15†) GF | |||||||
| 9 CV | |||||||||||
| MCA in olive oil | subcutaneous | 79% | 82% | fibrosarcoma | Wistar | ♀, ♂ | 14 GF, 11 CV | various | 1964 | [ | |
| 96% | 87% | Fisher | ♀, ♂ | 27 GF, 39 CV | |||||||
| Mice | MCA in olive oil | subcutaneous | 100% | 100% | fibrosarcoma | Swiss-Webster | ♀, ♂ | 13 GF, 14 CV | various | 1964 | [ |
| 80% | 72% | C3H | ♀, ♂ | 71 GF, 18 CV | |||||||
| 57% | ICR | ♀, ♂ | 33 GF | ||||||||
| 76% | CFW | ♀, ♂ | 17 GF | ||||||||
| 20-MCA in olive oil | orally | 94% | leukaemia | RFX | ♀, ♂ | 48 GF | 5–6 weeks | 1971 | [ | ||
| 27% | lung | 49 GF | |||||||||
| 20-MCA + croton oil | Orally—topically (abdomen skin) | 97% | leukaemia | 68 GF | |||||||
| 44% | lung | 62 GF | |||||||||
| MCA in olive oil | subcutaneous | 100% | 89% | lung | Swiss-Webster | ♀, ♂ | 61 GF, 54 CV | newborn | 1963 | [ | |
| Urethane | intra peritoneal | 56% | 85% | lung | BALB/c | ♀ | 17 GF, 20 CV | 6–9 weeks | 1970 | [ | |
| 0% | 25% | C3H/HeN | ♀ | 4 GF, 20 CV | |||||||
| 0% | 27% | C57Bl/6N | ♀ | 10 GF, 22 CV | |||||||
| 0% | 14% | C57Bl/6N | ♂ | 3 GF, 22 CV | |||||||
| mineral oil | intra peritoneal | 6% | 70% | plasma cell | BALB/c AnN | ♀ | 33 GF, 40 CV | 1–2 months | 1969 | [ | |
| 6% | 5% | pulmonary adenoma | |||||||||
| 48% | 10% | pleomorfic reticulum sarcoma |
Acronym of chemicals. DMBA: 7, 12-dimethylbenz(a)-anthracene; MCA: Methylcholanthrene.
Figure 1AOM-induced CRC in rat. AOM is an azide compound, active derivative of DMH and induces genetic damage in the colon cells. The carcinogen promotes classical colon carcinogenesis events with adenomas to carcinoma progression [56]. (A) aberrant crypts with (B) overexpression of p21 k-ras protein (dark brown) and (C) development of infiltrating adenocarcinoma after 32 weeks from the induction (original microphotographs from Luca Vannucci’s Lab archive).
Colorectal cancer induction by carcinogens in GF rats and mice.
| Induced Tumors | Dietary Component/Carcinogen | Method of Administation | Incidence GF % | Incidence CV % | Number of CRC Tumors/Animal | Type of Tumor—Specified | Strain | Gender | n. of Animals | Age (Weight) of Animals at the Start of Experiment | Year | Citation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rats | MNNG (increasing from 1 mg to 3 mg/rat and week, 20 weeks) | intra-rectal | 100% | 100% | 5.8 ± 0.58 GF | Fisher | ♀ | 24 GF | 50 days | 1975 | [ | |
| 3.00 ± 0.31 CV | 23 CV | |||||||||||
| MNNG (100 μg/mL) | in drinking water ad libitum | 17% | 91% | ns | Wistar | ♂ | 30 GF, 33 CV | 80–95 g | 1979 | [ | ||
| MNNG (16 mg/rat total dose) | intra-rectal | 89% | 2.7 ± 0.39 | Fisher 344 | ♀ | 16 GF | 7 weeks | 1976 | [ | |||
| MNNG (16 mg/rat) + DC (3 g/rat total dose) | 82% | 4.2 ± 0.5 | 22 GF | |||||||||
| DMH (20 weeks)—sacr. after last dose | subcutaneous | 0% | 17% | ns | CD Fisher | ♀ | 12 GF, 12 CV | 7 weeks | 1974 | [ | ||
| DMH (20 weeks)—sacr. 20 weeks after last dose (40 weeks total) | 11% | 25% | 18 GF, 24 CV | |||||||||
| DMH (20 mg/kg/week; 20 weeks) | intra-rectal | 43% | 86% | 1.0 ± 0.1 GF | Fisher | ♀ | 28 GF | 7 weeks | 1976 | [ | ||
| 2.1 ± 0.2 CV | 28 CV | |||||||||||
| AOM (10 mg/kg/week; 20 weeks) | subcutaneous | 100% | 60% | 7.4 ± 0.8 GF | 20 GF | |||||||
| 1.1 ± 0.2 CV | 28 CV | |||||||||||
| Bracken | mixed with diet | 90% | 94% | all CRC tumors | Wistar | ♀ | 10 GF, 16 CV | 80–90 g | 1981 | [ | ||
| 70% | 50% | adenoma | ||||||||||
| 0% | 63% | adenocarcinoma | ||||||||||
| 90% | 31% | sarcoma | ||||||||||
| AOM (9 mg/kg), 1x week, 5 weeks + bile (3 mL—3x week, 3 weeks) | subcutaneous + intracecal (surgicaly created cecal hernia) | 50% | 77.7% | 1 GF | Wistar-AVN | ♂ | 10 GF | 150 g | 2008 | [ | ||
| 1.85 CV | 10 CV |
Acronyms of chemicals. MNNG: Methylnitronitrosoguanidine; DC: deoxycholate; DMH: 1,2 dimethylhydrazine; AOM: azoxymethane.
Examples of carcinogenesis with AOM and induced colitis in GF animals.
| Species | Chemical | Method of Administation | Incidence GF % | Incidence CV/CVz % | Medical Conditions | Strain | Gender | n. of Animals | Age (Weight) of Animals at the Start of Experiment | Year | Citation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mice | DSS 5% and 1% | Orally—drinking water | 84% | 10% | colitis | IQI/Jic | ♀ | 19 (−6†) GF | 6–7 weeks | 2001 | [ |
| 10 CVz | |||||||||||
| DSS 2.5% | orally—drinking water | 53% | 44% | acute and chronic colitis | BALB/c | 15 (−5†) GF | 6–7 weeks | 2001 | [ | ||
| 18 (−4†) CV | |||||||||||
| 75% | 86% | SCID | 16 (−8†) GF | ||||||||
| 14 (−6†) CV | |||||||||||
| AOM (10 mg/kg), DSS 1–2.5% | orally—drinking water | 100% * | 0% * | colitis | C57BL/6 | GF | 6–12 weeks | 2013 | [ | ||
| CV | |||||||||||
| Guinea pigs | Carrageenan 5% | orally—drinking water | 0% | 100% | Cecal ulceration | Hartley strain guinea pigs | ♂ | 6 GF | 250–300 g | 1981 | [ |
| 142 CV |
Acronyms:.DSS: dextran sodium sulphate; AOM: azoxymethane; SCID: severe combined immundeficiency. * mortality after DSS >2%